相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?
Umberto Galderisi et al.
STEM CELL REVIEWS AND REPORTS (2022)
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome
Stefania Crippa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy
Yu Fu et al.
CELL DEATH & DISEASE (2021)
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children
Joanne Kurtzberg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
Joanne Kurtzberg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
Madan Jagasia et al.
BLOOD (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Erik Boberg et al.
STEM CELLS TRANSLATIONAL MEDICINE (2020)
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study
Adrian J. C. Bloor et al.
NATURE MEDICINE (2020)
New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
Nathaniel Edward Bennett Saidu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
Martino Introna et al.
FRONTIERS IN IMMUNOLOGY (2020)
A Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease
Rupal P. Soder et al.
STEM CELL REVIEWS AND REPORTS (2020)
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
Mary Thompson et al.
ECLINICALMEDICINE (2020)
Challenges for mesenchymal stromal cell therapies
Ivan Martin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease
E. Ilker Ozay et al.
STEM CELL RESEARCH (2019)
Janus Kinase Inhibition for Graft-Versus-Host Disease: Current Status and Future Prospects
Daniele Mannina et al.
DRUGS (2019)
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
Andreas Robert Rudolf Weiss et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
Carl Randall Harrell et al.
CELLS (2019)
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
Peter Bader et al.
BONE MARROW TRANSPLANTATION (2018)
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Jacques Galipeau et al.
CELL STEM CELL (2018)
Good responses but high TRM in adult patients after MSC therapy for GvHD
U. Salmenniemi et al.
BONE MARROW TRANSPLANTATION (2017)
Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience
Cornelis N. De Jong et al.
PLOS ONE (2017)
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
Antonio Galleu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
Manuel Jurado et al.
CYTOTHERAPY (2017)
Aging of bone marrow- and umbilical cord-derived mesenchymal stromal cells during expansion
Samantha F. H. De Witte et al.
CYTOTHERAPY (2017)
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation
G. M. Dotoli et al.
BONE MARROW TRANSPLANTATION (2017)
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study
Kazuo Muroi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome
Felix von Dalowski et al.
STEM CELLS (2016)
Mechanisms of mesenchymal stem/stromal cell function
Jeffrey L. Spees et al.
STEM CELL RESEARCH & THERAPY (2016)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Immunomodulation Effects of Mesenchymal Stromal Cells on Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation
Ke Zhao et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance
Nina Ketterl et al.
STEM CELL RESEARCH & THERAPY (2015)
How we treat chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2015)
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
Martino Introna et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
Fermin Sanchez-Guijo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Current issues in chronic graft-versus-host disease
Gerard Socie et al.
BLOOD (2014)
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Ratti Ram Sharma et al.
TRANSFUSION (2014)
Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
Joo Han Park et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease
Yoshihiro Inamoto et al.
BLOOD (2013)
Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells
Georg Siegel et al.
BMC MEDICINE (2013)
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease
Lynne M. Ball et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
Jacques Galipeau
CYTOTHERAPY (2013)
Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study
Kazuo Muroi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation
Yuguo Lei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin
Heike Wegmeyer et al.
STEM CELLS AND DEVELOPMENT (2013)
Treatment and management of graft-versus-host disease: improving response and survival
Catherine Garnett et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
Lena von Bahr et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study
Richard Herrmann et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study
Vinod K. Prasad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial
Jose A. Perez-Simon et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population
Giovanna Lucchini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study
Nobuyoshi Arima et al.
CYTOTHERAPY (2010)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M. von Bonin et al.
BONE MARROW TRANSPLANTATION (2009)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process
Wolfgang Wagner et al.
PLOS ONE (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Olle Ringden et al.
TRANSPLANTATION (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
